Back
Immunome, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
43
IMNM
Immunome, Inc.
Last Price:
$20.09
Seasonality Move:
57.07%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMNM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Immunome, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.41 | Buy |
| 20-day SMA: | 17.48 | Buy |
| 50-day SMA: | 15.64 | Buy |
| 200-day SMA: | 10.62 | Buy |
| 8-day EMA: | 18.27 | Buy |
| 20-day EMA: | 17.58 | Buy |
| 50-day EMA: | 15.76 | Buy |
| 200-day EMA: | 12.31 | Buy |
Immunome, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 63.24 | Buy |
| Chaikin Money Flow: | 1659621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16 - 18.38) | Buy |
| Bollinger Bands (100): | (9.58 - 16.1) | Buy |
Immunome, Inc. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Immunome, Inc. Stock
Is Immunome, Inc. Stock a Buy?
-
Immunome, Inc. share price is 19.37 while IMNM 8-day simple moving average is 18.41, which is a Buy signal.
-
The stock price of IMNM is 19.37 while Immunome, Inc. 20-day SMA is 17.48, which makes it a Buy.
-
Immunome, Inc. 50-day simple moving average is 15.64 while IMNM share price is 19.37, making it a Buy technically.
-
IMNM stock price is 19.37 and Immunome, Inc. 200-day simple moving average is 10.62, creating a Buy signal.
IMNM Technical Analysis vs Fundamental Analysis
Sell
43
Immunome, Inc. (IMNM)
is a Sell
Is Immunome, Inc. a Buy or a Sell?
-
Immunome, Inc. stock is rated a SellThe current Immunome, Inc. [IMNM] share price is $19.37. The Score for IMNM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Immunome, Inc. Stock Info
Market Cap:
1.8B
Price in USD:
19.37
Share Volume:
2.1M
Immunome, Inc. 52-Week Range
52-Week High:
19.66
52-Week Low:
5.15
Sell
43
Immunome, Inc. (IMNM)
is a Sell
Immunome, Inc. Share Price Forecast
-
What is the Immunome, Inc. stock price today?The Immunome, Inc. stock price is 19.37 USD today.
-
Will IMNM stock go up or go down?Immunome, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Immunome, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immunome, Inc. is overvalued.
Is Immunome, Inc. Stock a Buy?
-
Immunome, Inc. share price is 19.37 while IMNM 8-day exponential moving average is 18.27, which is a Buy signal.
-
The stock price of IMNM is 19.37 while Immunome, Inc. 20-day EMA is 17.58, which makes it a Buy.
-
Immunome, Inc. 50-day exponential moving average is 15.76 while IMNM share price is 19.37, making it a Buy technically.
-
IMNM stock price is 19.37 and Immunome, Inc. 200-day simple moving average is 12.31, creating a Buy signal.
Fundamental Analysis of Immunome, Inc.
Is Immunome, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Immunome, Inc.
Should I short Immunome, Inc. stock?
-
IMNM Moving Average Covergence Divergence (MACD) indicator is 0.85, suggesting Immunome, Inc. is a Buy
-
Immunome, Inc. Relative Strength Index (RSI) is 63.24, which suggest Immunome, Inc. is overbought
-
The Bollinger Bands (25) for Immunome, Inc. is (16 - 18.38), which suggest Immunome, Inc. is a Buy
-
The Bollinger Bands (100) for Immunome, Inc. is (9.58 - 16.1), which suggest Immunome, Inc. is a Buy
* Immunome, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.